Nathalie Chaput

12PUBLICATIONS
150CO-AUTHORS
Predictive and prognostic markersMolecular targetsComputational neuroscience (incl. mathematical neuroscience and theoretical neuroscience)Cancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (12)

|Jan 13, 2026
Circulating Transcriptome Analysis Finds Gene Signatures and Immune Cell Activation and Abundance Predict Response to Immunotherapy in Bladder Cancer.

Sandy Chevrier, Corentin Richard, Olivier Adotévi

|Aug 05, 2025
High Circulating IL-6/IL-8 Is Associated with Intratumoral Myeloid Contexture and Poor Outcomes in Patients with Advanced Renal Cell Carcinoma Treated with PD-1 Blockade.

Lucía Carril-Ajuria, Ronan Flippot, Marie Naigeon

|Oct 22, 2024
Metabolic Tumor Volume Assessed by 18F FDG-PET CT Scan as a Predictive Biomarker for Immune Checkpoint Blockers in Advanced NSCLC and Its Biological Correlates.

Filippo G Dall'Olio, Wael Zrafi, Veronique Roelants

|Apr 17, 2024
B cells and the coordination of immune checkpoint inhibitor response in patients with solid tumors.

Ronan Flippot, Marcus Teixeira, Macarena Rey-Cardenas

|Nov 08, 2023
Human virome profiling identified CMV as the major viral driver of a high accumulation of senescent CD8+ T cells in patients with advanced NSCLC.

Marie Naigeon, Matthieu Roulleaux Dugage, François-Xavier Danlos

|Jan 20, 2023
Genomic Instability and Protumoral Inflammation Are Associated with Primary Resistance to Anti-PD-1 + Antiangiogenesis in Malignant Pleural Mesothelioma.

François-Xavier Danlos, Matthieu Texier, Bastien Job

Pageof 2

Frequent Collaborators

6 joint publications

Aurelien Marabelle

4 joint publications

Marie Naigeon

3 joint publications

François-Xavier Danlos

3 joint publications

Benjamin Besse